SB-913

· Sangamo Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB-913, covering 2022-09-27 to 2024-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX